Immunic, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $73.7M | $60.4M | $56.9M |
| FY2018 | $1.9M | $13.4M | $13.1M |
| FY2019 | $7.6M | $66.0M | $29.4M |
| FY2020 | $9.1M | $167.9M | $127.5M |
| FY2021 | $12.0M | $139.1M | $86.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $73.7M | $60.4M | $56.9M |
| FY2018 | $1.9M | $13.4M | $13.1M |
| FY2019 | $7.6M | $66.0M | $29.4M |
| FY2020 | $9.1M | $167.9M | $127.5M |
| FY2021 | $12.0M | $139.1M | $86.9M |